Building supply chain resilience into oligonucleotide CMC from day 1

“The companies that succeed will be those that treat the supply chain as part of molecule design and CMC strategy...”

Jokūbas Leikauskas, Editor, Nucleic Acid Insights , speaks with Mayurbhai Patel, Vice President, CMC and Chemistry Development, Judo Bio, about resilience in the nucleic acid raw material supply chain, the promise and limits of enzymatic synthesis, how conjugation strategy shapes manufacturability, and why supply chain thinking belongs in CMC strategy from candidate selection onward.

Please enter your email to access content Read now